• Proceedings of the Safety Management and Science Conference
• /
• 1999.11a
• /
• pp.565-574
• /
• 1999

In reverse engineering area, it is rapidly developing reconstruction of surfaces from scanning or digitizing data, but geometric models of existing objects unavailable many industries. This paper describes new methodology of reverse engineering area, good strategies and important algorithms in reverse engineering area. Furthermore, proposing reconstruction of surface technique is presented. A method find base geometry and blending surface between them. Each based geometry is divided by triangular patch which are compared their normal vector for face grouping. Each group is categorized analytical surface such as a part of the cylinder, the sphere, the cone, and the plane that mean each based geometry surface. And then, each based geometry surface is implemented infinitive surface. Infinitive average surface's intersections are trimmed boundary representation model reconstruction. This method has several benefits such as the time efficiency and automatic functional modeling system in reverse engineering. Especially, it can be applied 3D scanner and 3D copier.

• Journal of the Korea Safety Management & Science
• /
• v.3 no.2
• /
• pp.167-179
• /
• 2001

In this study, an overall survey of ERP system and methodology are first introduced, then an efficient way of const겨cting ERP system is suggested through a case study on S company S company has not reached the goal of ERP system as it planned and is still working on the project. The main idea for the efficient construction methodology of ERP system is that BPR (Business Process Reengineering) should be accomplished and the company should have enough time to test the ERP package and a proper ERP team organization before the ERP system is introduced. It is suggested that introduction of ERP system bring about benefits to companies in terms of effective management system.

• Proceedings of the Safety Management and Science Conference
• /
• 2003.05a
• /
• pp.37-42
• /
• 2003

Recently, information systems(IS) outsourcing has become a very important management strategy of implementing IS and many studies on the IS outsourcing approach had been largely performed in the organizations, but it isn't still show how to outsource the IS functions and how to decide quantitative magnitude for judgement. To offer a quantitative decision model that can help practitioners set priority and reap the most benefits from outsourcing, we show outsourcing structure including 3 factors(strategic benefit, economic benefit and technological benefit) and sub-levels which. is different from the Yang and Huang's model. Also, we compute the weight of alternatives using analytic hierarchy process to find a priority of the IS outsourcing. As a result of analysis, we suggest systematic steps and quantitative model to increase the precision of decision making.

• Journal of Society of Preventive Korean Medicine
• /
• v.12 no.3
• /
• pp.141-155
• /
• 2008

Traditional, complementary, and alternative medicine(CAM) constitutes a major source of health care in developing countries. Its therapies, products and practices are increasing used in industrialized countries, typically by around 50% of the population. However, controls on the provider of CAM services and supply and promotion of complementary medicines are weak in these countries. These trends evoke important public health questions relating to benefits and detriments, safety and quality from medical, financial, and social perspectives. In the western counties, investment in research is increasing, and some guideline is now available for ensuring their quality, efficacy, and safety according to the criteria of evidence-based medicine as legally demanded. National policies and legislation are being developed in many countries and often include partnerships between biomedical and traditional health practitioners. The purposes of the study were to review the policies on CAM, to examine the responses of the government to cope with use of CAM in industrialized countries. Lastly, some implications and recommendation are suggested.

• Journal of the Korean Society of Safety
• /
• v.23 no.6
• /
• pp.34-37
• /
• 2008

The composite materials are widely used in the many applications of industry as well as aerospace field because of their high specific stiffness and strength which benefits the material and provides potential energy savings. However, composite materials also have a low property about external applied impact. In this paper, impact tests were conducted on different sample types(glass, carbon and kevlar composite) to obtain information such as absorbed energy and composite deformation using an instrumented impact test machine (DYNATUP 8250). 3 type samples were compared to experimental results. The data from impact test provided valuable information between the different type samples by wet lay up. This paper shows results of that kevlar composite has larger absorption energy and deformation than others.

• Transactions of the Korean Society of Mechanical Engineers A
• /
• v.29 no.1 s.232
• /
• pp.139-144
• /
• 2005

A vehicle cruise control algorithm using an Interacting Multiple Model (IMM)-based Multi-Target Tracking (MTT) method has been presented in this paper. The vehicle cruise control algorithm consists of three parts; track estimator using IMM-Probabilistic Data Association Filter (PDAF), a primary target vehicle determination algorithm and a single-target adaptive cruise control algorithm. Three motion models; uniform motion, lane-change motion and acceleration motion. have been adopted to distinguish large lateral motions from longitudinal motions. The models have been validated using simulated and experimental data. The improvement in the state estimation performance when using three models is verified in target tracking simulations. The performance and safety benefits of a multi-model-based MTT-ACC system is investigated via simulations using real driving radar sensor data. These simulations show system response that is more realistic and reflective of actual human driving behavior.

• Journal of the Korea Safety Management & Science
• /
• v.19 no.4
• /
• pp.183-188
• /
• 2017

Block Chain is a technology that records and shares distributed ledgers without a central authority, providing a decentralized platform for transparent transactions in the business and enhancing transparency and traceability in all transactions to ensure trust in the transaction. Despite initial doubts about this technology, it is committed to adopting, adapting and improving the technology in a wide range of industries, including finance, government, security, logistics, food, medical, legal, and real estate. This study examines this technology, its applicability and potential benefits to the manufacturing supply chain. A tracking system of manufacturing supply chain to visualize transparency and traceability is implemented, and the conditions for adopting the technology in the manufacturing supply chain and the issues to be addressed are discussed.

• Medical Lasers
• /
• v.10 no.2
• /
• pp.68-75
• /
• 2021

Medical lasers have been widely used for various diseases. Despite the notable benefits, lasers could cause several complications such as skin burn, eye injury, airway fire, and so on. These accidents may occur not only with patients, users of the laser, or laser handlers but also to people passing in front of the laser treatment room. Although there is a risk associated with the laser, most of them can be prevented through good training, use of proper protection equipment, and ensuring the safe operation of the laser at all times. Due to the increasing use of lasers and the growing interest in their use, medical institutions should particularly emphasize the safe use of lasers and introduce systems for laser safety.

• Journal of Arbitration Studies
• /
• v.10 no.1
• /
• pp.92-113
• /
• 2000

Products liability refers to the liability of any or all parties along the chain of manufacture of any product for damage caused by that product. This includes the manufacturer of component parts (at the top of the chain), an assembling manufacturer, the wholesaler, and the retail store owner (at the bottom of the chain). Products containing inherent defects that cause harm to a consumer of the product, or someone to whom the product was loaned, given, etc., are the subjects of products liability suits. The goal of products liability system should be to maximize consumer welfare by efficiently providing just compensation for injuries incurred and deterring future injuries without unreasonably impeding the supply of the goods and services to consumers. Some advanced countries, apart from relying on products liability systems, also apply other policies and legislation directly aimed at the safety of the consumer. The application of general safety policies as well as products liability rules is not costless. An efficient system will not eliminate risk from society. An efficient system ... that maximises consumer welfare ... maximises the benefits while minimising the costs. Products liability claims can be based on negligence, strict liability, or breach of warranty of fitness depending on the jurisdiction where the claim is based. In view of international business and law circumstances, it should be stressed that international enterprises in Korea should consider how to cope with the situation of international transaction. International enterprises should have a correct perception about products liability which is to contribute the stabilization and improvement of the people's life and the sound develpement of the national economy. Products liability system creates incentives that influence behaviour and performance in ways that are desirable, such as more diligent monitoring to prevent defective products from reaching the market-place. At the same time, any liability system will impose burdens that are undesirable, such as greater costs imposed on business and consumers and reduced avaiability of consumer goods. The concern for society is to balance. The ideal situation is where the cost imposed on producers of goods and services pushes them to a desirable level of care but not so far that producers reach undesirable level of caution that may deprive consumers unnecessarily of the benefits from new and innovative products.

• Asian Pacific Journal of Cancer Prevention
• /
• v.15 no.5
• /
• pp.2369-2374
• /
• 2014

Background and Aim: Selumetinib is a promising and interesting targeted therapy agent as it may reverse radioiodine uptake in patients with radioiodine-refractory differentiated thyroid cancer. We conduct this metaanalysis to compare the efficacy and safety of selumetinib with current therapies in patients with advanced cancer. Methods: An electronic search was conducted using PubMed/ Medicine, EMBASE and Cochrane library databases. Statistical analyses were carried out using either random-effects or fixed-effects models according to the heterogeneity of eligible studies. Results: Six eligible trials involved 601 patients were identified. Compared with current therapies, treatment schedules with selumetinib did not improve progression free survival (hazard ratio, 0.91; 95%CI 0.70-1.17, P= 0.448), but did identify better clinical benefits (odds ratio, 1.24; 95%CI 0.69-2.24, P = 0.472) and less disease progression (hazard ratio, 0.72; 95%CI 0.51-1.00, P = 0.052) though its impact was not statistically significant. Sub-group analysis resulted in significantly improved progression free survival (hazard ratio, 0.61; 95%CI 0.49-0.57, P = 0.00), clinical benefits (odds ratio, 3.04; 95%CI 1.60-5.77, P = 0.001) and reduced disease progression (hazard ratio, 0.35; 95%CI 0.18-0.67, P = 0.001) in patients administrated selumetinib. Dermatitis acneiform (risk ratio, 9.775; 95%CI 3.143-30.395, P = 0.00) and peripheral edema (risk ratio, 2.371; 95%CI 1.690-3.327, P = 0.00) are the most frequently observed adverse effects associated with selumetinib. Conclusions: Compared with current chemotherapy, selumetinib has modest clinical activity as monotherapy in patients with advanced cancer, but combinations of selumetinib with cytotoxic agents in patients with BRAF or KRAS mutations hold great promise for cancer treatment. Dermatitis acneiform and peripheral edema are the most frequently observed adverse effects in patients with selumetinib.